Recently, the fifth subtype has also been proposed named SCLC-A2 (also labeled as NEv2) which is driven by ASCL1 but distinct from the SCLC-A neuroendocrine subtype [38]. This evidence concerns the gene ASCL1 and small cell lung carcinoma.